Waters has signed an instrument control agreement with Agilent and recognized Chang Gung University as a Center of Innovation Partner.
The conference was relatively light on new mass spec launches, with many vendors focusing instead on more targeted applications of existing technology.
The company posted revenues of $460.4 million compared to $430.5 million in Q1 2014, beating the average Wall Street estimate of $445.3 million.
The amendment to a 2013 debt financing agreement will increase revolving commitments to $1.3 billion, extend maturity of loans, and adjust interest rates and fees.
Interest in detection directly from specimens and antibiotic resistance is leading some researchers to look at methods likeREIMSand MRM-MS.
The agency approved the Acquity UPLC I-Class IVD/Xevo TQ-S IVD LC-MS for clinical analysis of various targets.
Many of the meeting's proteomics presentations concerned not so much mass spec analysis itself as the refinement of processes and workflows leading up to it.
PerkinElmer's liquid and gas chromatography portfolio will be standardized on Waters' Empower Software.
The company's total revenues increased to $584 million from $565 million in the prior-year period, besting the consensus analyst estimate of $582 million.
From research collaborations to corporate acquisitions, attention from the broader scientific community highlighted the field's capabilities and limitations.
The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.
Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.
NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.
In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.